Case number 2018-1203
Sanofi Mature IP v. Mylan Laboratories Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | SANOFI MATURE IP v. MYLAN LABORATORIES LIMITED [OPINION - NONPRECEDENTIAL] [nonprecedential] (0) |
| Mar 14, 2019 | 65 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [592714] [PBC] [Entered: 03/14/2019 08:44 AM] (0) |
| Feb 5, 2019 | 64 | JUDGMENT filed. VACATED AND REMANDED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [583374] [PBC] [Entered: 02/05/2019 09:13 AM] (0) |
| Feb 5, 2019 | 63 | OPINION filed for the court by Prost, Chief Judge; O'Malley, Circuit Judge and Stoll, Circuit Judge. Nonprecedential Opinion. [583372] [PBC] [Entered: 02/05/2019 09:12 AM] (0) |
| Jan 28, 2019 | 62 | ORDER filed granting motion to substitute party [56] filed by Appellant Aventis Pharma S.A. Appellant Aventis Pharma S.A. substituted by Appellant Sanofi Mature IP in 18-1203. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [581477] [JAB] [Entered: 01/28/2019 03:17 PM] (0) |
| Jan 24, 2019 | 61 | Amended Entry of appearance for Katherine E. Adams as of counsel for Appellant Aventis Pharma S.A. Sanofi Mature IP. Service: 01/24/2019 by email. [580603] [18-1203] [William Solander] [Entered: 01/24/2019 01:27 PM] (0) |
| Jan 24, 2019 | 60 | Amended Entry of appearance for Whitney L. Meier as of counsel for Appellant Aventis Pharma S.A. Sanofi Mature IP. Service: 01/24/2019 by email. [580601] [18-1203] [William Solander] [Entered: 01/24/2019 01:25 PM] (0) |
| Jan 24, 2019 | 59 | Amended Entry of appearance for Daniel J. Minion as of counsel for Appellant Aventis Pharma S.A. Sanofi Mature IP. Service: 01/24/2019 by email. [580600] [18-1203] [William Solander] [Entered: 01/24/2019 01:23 PM] (0) |
| Jan 24, 2019 | 58 | Amended Entry of appearance for Dominick A. Conde as of counsel for Appellant Aventis Pharma S.A. Sanofi Mature IP. Service: 01/24/2019 by email. [580599] [18-1203] [William Solander] [Entered: 01/24/2019 01:21 PM] (0) |
| Jan 24, 2019 | 57 | Amended Entry of appearance for William E. Solander as principal counsel for Appellant Aventis Pharma S.A. Sanofi Mature IP. Service: 01/24/2019 by email. [580598] [18-1203] [William Solander] [Entered: 01/24/2019 01:19 PM] (0) |
| Jan 24, 2019 | 56 | MOTION of Sanofi Mature IP Appellant Aventis Pharma S.A. to substitute party [Consent: unopposed]. Service: 01/24/2019 by email. [580595] [18-1203] [William Solander] [Entered: 01/24/2019 01:17 PM] (0) |
| Jan 9, 2019 | 55 | Amended Certificate of Interest for the Appellant Aventis Pharma S.A.. Service: 01/09/2019 by email. [577140] [18-1203] [Whitney Meier] [Entered: 01/09/2019 06:31 PM] (3) |
| Dec 4, 2018 | 54 | Submitted after ORAL ARGUMENT by Mr. Daniel John Minion for Aventis Pharma S.A. and Mr. Matthew R. Reed for Mylan Laboratories Limited. Panel: Judge: Prost , Judge: O'Malley , Judge: Stoll. [569560] [JCP] [Entered: 12/04/2018 11:46 AM] (0) |
| Nov 15, 2018 | 53 | CORRECTED Response to oral argument order from the Appellee Mylan Laboratories Limited.[565408] [18-1203] [Steven Parmelee] [Entered: 11/15/2018 03:13 PM] (3) |
| Nov 15, 2018 | 52 | Response to oral argument order from the Appellant Aventis Pharma S.A..[565378] [18-1203] [Katherine Adams] [Entered: 11/15/2018 02:30 PM] (3) |
| Nov 15, 2018 | 51 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [50], ERROR: Counsel for Appellee Mylan Laboratories Limited submitted a response to notice of oral argument designating 0 minutes for argument and 15 minutes for rebuttal. Appellees do not receive rebuttal time at argument. CORRECTION: Please promptly file a corrected response. [565326] [JAB] [Entered: 11/15/2018 01:28 PM] (0) |
| Nov 14, 2018 | 50 | Response to oral argument order from the Appellee Mylan Laboratories Limited.[564964] [18-1203] [Steven Parmelee] [Entered: 11/14/2018 04:42 PM] (3) |
| Nov 6, 2018 | 49 | Amended Entry of appearance for Katherine E. Adams as of counsel for Appellant Aventis Pharma S.A.. Service: 11/06/2018 by email. [563096] [18-1203] [Katherine Adams] [Entered: 11/06/2018 05:44 PM] (2) |
| Nov 6, 2018 | 48 | Amended Entry of appearance for Whitney L. Meier as of counsel for Appellant Aventis Pharma S.A.. Service: 11/06/2018 by email. [563095] [18-1203] [Katherine Adams] [Entered: 11/06/2018 05:42 PM] (2) |
| Nov 6, 2018 | 47 | Amended Entry of appearance for Dominick A. Conde as of counsel for Appellant Aventis Pharma S.A.. Service: 11/06/2018 by email. [563094] [18-1203] [Katherine Adams] [Entered: 11/06/2018 05:40 PM] (2) |
| Nov 6, 2018 | 46 | Amended Entry of appearance for Daniel J. Minion as of counsel for Appellant Aventis Pharma S.A.. Service: 11/06/2018 by email. [563092] [18-1203] [Katherine Adams] [Entered: 11/06/2018 05:38 PM] (2) |
| Nov 6, 2018 | 45 | Amended Entry of appearance for William E. Solander as principal counsel for Appellant Aventis Pharma S.A.. Service: 11/06/2018 by email. [563091] [18-1203] [Katherine Adams] [Entered: 11/06/2018 05:36 PM] (2) |
| Oct 22, 2018 | 44 | NOTICE OF ORAL ARGUMENT. Panel: 1812F. Case scheduled Dec 04, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 11/15/2018. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [559093] [JAB] [Entered: 10/22/2018 12:12 PM] (2) |
| Jun 20, 2018 | 42 | Notice from Appellant Aventis Pharma S.A. regarding conflicts with oral argument (August 6-10, 2018; September 5-7, 2018; October 1-5, 2018). Service: 06/20/2018 by email. [530892] [18-1203] [Whitney Meier] [Entered: 06/20/2018 01:47 PM] (5) |
| Jun 20, 2018 | 41 | 6 paper copies of the Confidential Joint Appendix Brief [39] received from Appellant Aventis Pharma S.A.. [530822] [CJF] [Entered: 06/20/2018 10:50 AM] (0) |
| Jun 20, 2018 | 43 | Notice from Appellee Mylan Laboratories Limited regarding conflicts with oral argument (July 9-13, 2018; August 6-10, 2018; September 4-7, 2018; October 5, 2018; and December 5-7, 2018). Service: 06/20/2018 by email. [530968] [18-1203] [Steven Parmelee] [Entered: 06/20/2018 04:14 PM] (3) |
| Jun 13, 2018 | 40 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 06/20/2018. [529075] [CFT] [Entered: 06/13/2018 11:58 AM] (0) |
| Jun 11, 2018 | 39 | CORRECTED JOINT APPENDIX FILED for Aventis Pharma S.A. [36]. Number of Pages: 752. Service: 06/11/2018 by email. [529046] [CFT] [Entered: 06/13/2018 11:13 AM] (752) |
| Jun 11, 2018 | 38 | CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Aventis Pharma S.A. [37]. Number of Pages: 761. Service: 06/11/2018 by email. The paper copies of the brief should be received by the court on or before 06/20/2018. [529042] [CFT] [Entered: 06/13/2018 11:10 AM] (0) |
| Jun 11, 2018 | 37 | TENDERED from Appellant Aventis Pharma S.A. and Appellee Mylan Laboratories Limited. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 06/11/2018 by email. [528541] [18-1203] [Whitney Meier] [Entered: 06/11/2018 05:06 PM] (0) |
| Jun 11, 2018 | 36 | TENDERED from Appellant Aventis Pharma S.A. and Appellee Mylan Laboratories Limited. Title: CORRECTED JOINT APPENDIX. Service: 06/11/2018 by email. [528538] [18-1203] [Whitney Meier] [Entered: 06/11/2018 05:02 PM] (752) |
| May 29, 2018 | 35 | NOTICE OF REJECTION: The briefs of Appellant Aventis Pharma S.A., "Confidential Joint Appendix" and "Non-Confidential Joint Appendix" [31], [32], are not in compliance with the rules of this court and are therefore rejected for filing. Corrected Appendices are due 06/12/2018. Service as of this date by the Clerk of Court. [525031] [CFT] [Entered: 05/29/2018 01:10 PM] (2) |
| May 25, 2018 | 34 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellant Aventis Pharma S.A.. Service: 05/25/2018 by email. [524874] [18-1203] [William Solander] [Entered: 05/25/2018 05:29 PM] (5) |
| May 25, 2018 | 33 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Aventis Pharma S.A. and Appellee Mylan Laboratories Limited. Service: 05/25/2018 by email. [524872] [18-1203] [William Solander] [Entered: 05/25/2018 05:21 PM] (3) |
| May 25, 2018 | 32 | TENDERED from Appellant Aventis Pharma S.A. and Appellee Mylan Laboratories Limited. Title: CONFIDENTIAL JOINT APPENDIX Service: 05/25/2018 by email. [524871] [18-1203] This brief has been rejected. See Doc No. [35] [William Solander] [Entered: 05/25/2018 05:18 PM] (0) |
| May 25, 2018 | 31 | TENDERED from Appellant Aventis Pharma S.A. and Appellee Mylan Laboratories Limited. Title: JOINT APPENDIX. Service: 05/25/2018 by email. [524870] [18-1203] This brief has been rejected. See Doc No. [35] [William Solander] [Entered: 05/25/2018 05:14 PM] (0) |
| May 23, 2018 | 30 | 6 paper copies of the Reply Brief [29] received from Appellant Aventis Pharma S.A. [524118] [JCP] [Entered: 05/24/2018 08:21 AM] (0) |
| May 18, 2018 | 28 | TENDERED from Appellant Aventis Pharma S.A.. Title: REPLY BRIEF. Service: 05/18/2018 by email. [522952] [18-1203] [William Solander] [Entered: 05/18/2018 02:54 PM] (41) |
| May 18, 2018 | 29 | REPLY BRIEF FILED for Appellant Aventis Pharma S.A. [28]. Number of Pages: 29. Service: 05/18/2018 by email. The paper copies of the brief should be received by the court on or before 05/29/2018. Appendix is due 05/25/2018. [523281] [JB] [Entered: 05/21/2018 02:42 PM] (41) |
| May 15, 2018 | 27 | Entry of appearance for Katherine E. Adams as of counsel for Appellant Aventis Pharma S.A.. Service: 05/15/2018 by email. [521979] [18-1203] [Katherine Adams] [Entered: 05/15/2018 05:32 PM] (2) |
| May 3, 2018 | 26 | 6 paper copies of the Opening Response Brief [23] received from Appellee Mylan Laboratories Limited. [518810] [SJL] [Entered: 05/03/2018 01:19 PM] (0) |
| May 1, 2018 | 25 | **TEXT ONLY** ORDER granting motion to extend time to file brief [24] filed by Appellant Aventis Pharma S.A. Reply brief is due 05/18/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [518011] [CFT] [Entered: 05/01/2018 10:51 AM] (0) |
| Apr 30, 2018 | 24 | MOTION of Appellant Aventis Pharma S.A. to extend the time to 05/18/2018 to file the Appellant's Reply Brief. [Consent: unopposed]. Service: 04/30/2018 by email. [517849] [18-1203] [Whitney Meier] [Entered: 04/30/2018 04:41 PM] (7) |
| Apr 24, 2018 | 23 | BRIEF FILED for Appellee Mylan Laboratories Limited [22]. Number of Pages: 60. Service: 04/24/2018 by email. The paper copies of the brief should be received by the court on or before 05/03/2018. Appellant Aventis Pharma S.A. reply brief is due 05/08/2018. [517172] [JB] [Entered: 04/26/2018 04:25 PM] (73) |
| Apr 24, 2018 | 22 | TENDERED from Appellee Mylan Laboratories Limited. Title: RESPONSE BRIEF. Service: 04/24/2018 by email. [516629] [18-1203] [Steven Parmelee] [Entered: 04/24/2018 10:36 PM] (73) |
| Mar 22, 2018 | 21 | 6 paper copies of the Opening Brief [20] received from Appellant Aventis Pharma S.A. [507180] [SJL] [Entered: 03/22/2018 02:22 PM] (0) |
| Mar 15, 2018 | 20 | BRIEF FILED for Appellant Aventis Pharma S.A. [19]. Number of Pages: 64. Service: 03/15/2018 by email. The paper copies of the brief should be received by the court on or before 03/27/2018. Appellee Mylan Laboratories Limited brief is due 04/24/2018. [506627] [JB] [Entered: 03/20/2018 11:59 AM] (186) |
| Mar 15, 2018 | 19 | TENDERED from Appellant Aventis Pharma S.A.. Title: OPENING BRIEF. Service: 03/15/2018 by email. [505782] [William Solander] [Entered: 03/15/2018 10:34 PM] (186) |
| Feb 26, 2018 | 18 | **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [17] filed by Appellant Aventis Pharma S.A. Brief is due on 03/19/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [501090] [JB] [Entered: 02/26/2018 02:59 PM] (0) |
| Feb 23, 2018 | 17 | MOTION of Appellant Aventis Pharma S.A. to extend the time to 03/19/2018 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/23/2018 by email. [500871] [Whitney Meier] [Entered: 02/23/2018 06:19 PM] (7) |
| Jan 2, 2018 | 16 | Certified list from the United States Patent and Trademark Office. Service: 01/02/2018 by email. Appellant/Petitioner's brief is due 03/05/2018. [486970] [JB] [Entered: 01/03/2018 11:29 AM] (97) |
| Dec 19, 2017 | 15 | Amended Certificate of Interest for the Appellee Mylan Laboratories Limited. Service: 12/19/2017 by email. [483880] [Steven Parmelee] [Entered: 12/19/2017 03:34 PM] (3) |
| Dec 4, 2017 | 14 | Docketing Statement for the Appellee Mylan Laboratories Limited. Service: 12/04/2017 by email. [480131] [Steven Parmelee] [Entered: 12/04/2017 08:23 PM] (5) |
| Dec 4, 2017 | 13 | Certificate of Interest for the Appellee Mylan Laboratories Limited. Service: 12/04/2017 by email. [480130] [Steven Parmelee] [Entered: 12/04/2017 08:22 PM] (3) |
| Dec 4, 2017 | 12 | Entry of appearance for Wendy L. Devine as of counsel for Appellee Mylan Laboratories Limited. Service: 12/04/2017 by email. [480129] [Steven Parmelee] [Entered: 12/04/2017 08:21 PM] (2) |
| Dec 4, 2017 | 11 | Entry of appearance for Michael T. Rosato as of counsel for Appellee Mylan Laboratories Limited. Service: 12/04/2017 by email. [480128] [Steven Parmelee] [Entered: 12/04/2017 08:19 PM] (2) |
| Dec 4, 2017 | 10 | Entry of appearance for Matthew R. Reed as of counsel for Appellee Mylan Laboratories Limited. Service: 12/04/2017 by email. [480127] [Steven Parmelee] [Entered: 12/04/2017 08:18 PM] (2) |
| Dec 4, 2017 | 9 | Entry of appearance for Jad A. Mills as of counsel for Appellee Mylan Laboratories Limited. Service: 12/04/2017 by email. [480126] [Steven Parmelee] [Entered: 12/04/2017 08:17 PM] (2) |
| Dec 4, 2017 | 8 | Entry of appearance for Steven W. Parmelee as principal counsel for Appellee Mylan Laboratories Limited. Service: 12/04/2017 by email. [480125] [Steven Parmelee] [Entered: 12/04/2017 08:16 PM] (2) |
| Dec 4, 2017 | 7 | Docketing Statement for the Appellant Aventis Pharma S.A.. Service: 12/04/2017 by email. [480007] [Whitney Meier] [Entered: 12/04/2017 03:28 PM] (4) |
| Dec 4, 2017 | 6 | Certificate of Interest for the Appellant Aventis Pharma S.A.. Service: 12/04/2017 by email. [480003] [Whitney Meier] [Entered: 12/04/2017 03:26 PM] (3) |
| Dec 4, 2017 | 5 | Entry of appearance for Whitney L. Meier as of counsel for Appellant Aventis Pharma S.A.. Service: 12/04/2017 by email. [480001] [Whitney Meier] [Entered: 12/04/2017 03:25 PM] (2) |
| Dec 4, 2017 | 4 | Entry of appearance for Daniel J. Minion as of counsel for Appellant Aventis Pharma S.A.. Service: 12/04/2017 by email. [480000] [Whitney Meier] [Entered: 12/04/2017 03:23 PM] (2) |
| Dec 4, 2017 | 3 | Entry of appearance for Dominick A. Conde as of counsel for Appellant Aventis Pharma S.A.. Service: 12/04/2017 by email. [479996] [Whitney Meier] [Entered: 12/04/2017 03:22 PM] (2) |
| Dec 4, 2017 | 2 | Entry of appearance for William E. Solander as principal counsel for Appellant Aventis Pharma S.A.. Service: 12/04/2017 by email. [479992] [Whitney Meier] [Entered: 12/04/2017 03:20 PM] (2) |
| Nov 20, 2017 | 1 | Appeal docketed. Received: 11/17/2017. [476930] Entry of Appearance due 12/04/2017. Certificate of Interest is due on 12/04/2017. Docketing Statement due 12/04/2017. Certified List due on 01/02/2018. [JB] [Entered: 11/20/2017 11:32 AM] (91) |
